INITIAL ASSESSMENT OF TUMOR-ASSOCIATED ANTIGEN-CA-125 IN PATIENTS WITH OVARIAN, CERVICAL, AND TESTICULAR-TUMORS

被引：0
|
作者：
BUAMAH, PK
CORNELL, C
SKILLEN, AW
CANTWELL, BMJ
HARRIS, AL
机构：
[1] FREEMAN HOSP,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE7 7DN,ENGLAND
[2] NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
[3] MED SCH,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
来源：
CLINICAL CHEMISTRY | 1987年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1124 / 1125
页数：2
相关论文
共 50 条
  • [41] COMPARISON OF PORTAL AND PERIPHERAL-BLOOD LEVELS OF CARCINOEMBRYONIC ANTIGEN, CA-19-9, AND CA-125 TUMOR-ASSOCIATED ANTIGENS IN PATIENTS WITH COLORECTAL AND PANCREATIC-CANCER
    TALBOT, RW
    NAGORNEY, DM
    PEMBERTON, JH
    WIEAND, HS
    RITTS, RE
    CANCER RESEARCH, 1989, 49 (03) : 542 - 543
  • [42] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER
    CANNEY, PA
    MOORE, M
    WILKINSON, PM
    JAMES, RD
    BRITISH JOURNAL OF CANCER, 1984, 50 (06) : 765 - 769
  • [43] HUMAN TUMOR-ASSOCIATED ANTIGEN MIMICRY BY ANTIIDIOTYPIC ANTIBODIES - IMMUNOGENICITY AND CLINICAL-TRIALS IN PATIENTS WITH SOLID TUMORS
    FERRONE, S
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 690 : 214 - 224
  • [44] CANCER-ASSOCIATED ANTIGEN CA-195 IN PATIENTS WITH MUCINOUS OVARIAN-TUMORS - A COMPARATIVE-ANALYSIS WITH CEA, TATI AND CA-125 IN SERUM SPECIMENS AND CYST FLUIDS
    DEBRUIJN, HWA
    TENHOOR, KA
    BOONSTRA, H
    MARRINK, J
    KRANS, M
    AALDERS, JG
    TUMOR BIOLOGY, 1993, 14 (02) : 105 - 115
  • [45] CYTO-TOXICITY ON TUMOR-CELLS OF PERIPHERAL-BLOOD MONOCYTES AND TUMOR-ASSOCIATED MACROPHAGES IN PATIENTS WITH ASCITES OVARIAN-TUMORS
    MANTOVANI, A
    POLENTARUTTI, N
    PERI, G
    SHAVIT, ZB
    VECCHI, A
    BOLIS, G
    MANGIONI, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1980, 64 (06) : 1307 - 1315
  • [46] CHARACTERIZATION OF AN HSV-2 TUMOR-ASSOCIATED ANTIGEN AG4 REACTIVE WITH CERVICAL-CARCINOMA PATIENTS SERA
    FLANDERS, RT
    KUCERA, LS
    RICARDO, MJ
    PLUCKETT, S
    RABEN, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (01): : 79 - 80
  • [47] Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer
    Hofstetter, Gerda
    Grech, Christina
    Pils, Dietmar
    Pammer, Johannes
    Neudert, Barbara
    Potsch, Nina
    Baltzer, Pascal
    Traub-Weidinger, Tatjana
    Seebacher, Veronika
    Aust, Stefanie
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (04):
  • [48] CLINICAL COURSES OF PATIENTS WITH OVARIAN CARCINOMAS AFTER INDUCTION OF ANTIIDIOTYPIC ANTIBODIES AGAINST A TUMOR-ASSOCIATED ANTIGEN - AN APPROACH TO IMMUNOTHERAPY OF ADVANCED OVARIAN-CANCER
    WAGNER, U
    REINSBERG, J
    OEHR, P
    BRIELE, B
    SCHMIDT, S
    WERNER, A
    KREBS, D
    BIERSACK, HJ
    TUMORDIAGNOSTIK & THERAPIE, 1990, 11 (01) : 1 - 4
  • [49] CLINICAL-VALUE OF THE TUMOR-MARKER CA-125 IN PREOPERATIVE DIAGNOSIS AND POSTOPERATIVE MANAGEMENT OF PATIENTS WITH MALIGNANT OVARIAN TUMORS
    SEVELDA, P
    SALZER, H
    DITTRICH, C
    SPONA, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1985, 45 (11) : 769 - 773
  • [50] Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
    Chen, Fawen
    Shen, Jing
    Wang, Jianwei
    Cai, Pengwei
    Huang, Yi
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1313 - 1318
12345